Downregulation of lncRNA TSLNC8 promotes melanoma resistance to BRAF inhibitor PLX4720 through binding with PP1α to re-activate MAPK signaling
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-020-03484-4.pdf
Reference31 articles.
1. Ascierto PA et al (2013) Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma Journal of clinical oncology. Off J Am Soc Clin Oncol 31:3205–3211. https://doi.org/10.1200/JCO.2013.49.8691
2. Beroukhim R et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899–905. https://doi.org/10.1038/nature08822
3. Chapman PB et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507–2516. https://doi.org/10.1056/NEJMoa1103782
4. Cheetham SW, Gruhl F, Mattick JS, Dinger ME (2013) Long noncoding RNAs and the genetics of cancer. Br J Cancer 108:2419–2425. https://doi.org/10.1038/bjc.2013.233
5. Chen D, Yu X (2018) Long noncoding RNA TSLNC8 suppresses cell proliferation and metastasis and promotes cell apoptosis in human glioma. Mol Med Rep 18:5536–5544. https://doi.org/10.3892/mmr.2018.9609
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21
2. Metformin Regulates the Proliferation and Motility of Melanoma Cells by Modulating the LINC00094/miR-1270 Axis;2024-07-29
3. Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening;Anticancer Research;2024-05-31
4. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer;Pathology - Research and Practice;2024-01
5. Exosomal Non-coding RNAs: A New Approach to Melanoma Diagnosis and Therapeutic Strategy;Current Medicinal Chemistry;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3